Iontophoretic Terbinafine HCL 1.0% Delivery Across Porcine and Human Nails

被引:20
作者
Amichai, Boaz [1 ]
Mosckovitz, Rachel [2 ]
Trau, Henri [3 ]
Sholto, Orit [2 ]
Ben-Yaakov, Shirly [2 ]
Royz, Michael [2 ]
Barak, David [2 ]
Nitzan, Boaz [2 ]
Shemer, Avner [3 ]
机构
[1] Clalit Hlth Serv, Huzot Clin, Ashqelon, Israel
[2] Power Paper Ltd, Res Dept, Petah Tiqwa, Israel
[3] Chaim Sheba Med Ctr, Dept Dermatol, IL-52621 Tel Hashomer, Israel
关键词
Iontophoresis; Nail; Terbinafine; Onychomycosis; DRUG-DELIVERY; CHEMICAL ENHANCEMENT; ANTIFUNGAL THERAPY; ONYCHOMYCOSIS; TRANSPORT; SKIN;
D O I
10.1007/s11046-009-9265-x
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background Onychomycosis is a common disease. Topical treatment is usually not effective due to limitation of trans-nail delivery of antifungal drugs. Successful treatment of deep-seated nail infections remains elusive as the delivery of efficacious levels of antifungal drug to the site of action is very difficult. Objectives To evaluate the influence of several parameters including; the effect of low electrical current, incubation time and the presence of electrolyte (NaCl or KCl) on the penetration of terbinafine through the nail plate into the nail bed, using various formulations and concentrations of terbinafine HCl. Methods Iontophoresis was applied across porcine and human nail in vitro to assess its efficiency in enhancing delivery of terbinafine HCl. Results In this study, we have demonstrated that an optimal electrolyte concentration (1% NaCl or KCl) is required for an effective delivery. There is a significant increase in drug delivery into the nail and into the receiving compartment in the presence of 3% DMSO. Conclusions This study demonstrates the efficacy of iontophoresis in enhancing the trans-nail delivery of terbinafine. Clinical studies are needed to evaluate the feasibility, efficacy and safety of iontophoresis of terbinafine in onychomycosis in human.
引用
收藏
页码:343 / 349
页数:7
相关论文
共 22 条
[1]  
AMICHAI B, 2009, BR J DERMATOL
[2]   Review of antifungal therapy, part II: Treatment rationale, including specific patient populations [J].
Baran, Robert ;
Hay, Rod J. ;
Garduno, Javier I. .
JOURNAL OF DERMATOLOGICAL TREATMENT, 2008, 19 (03) :168-175
[3]   Review of antifungal therapy and the severity index for assessing onychomycosis: Part I [J].
Baran, Robert ;
Hay, Rod J. ;
Garduno, Javier I. .
JOURNAL OF DERMATOLOGICAL TREATMENT, 2008, 19 (02) :72-81
[4]  
Dixit Nitin, 2007, Current Drug Delivery, V4, P1, DOI 10.2174/156720107779314802
[5]   Prevalence of onychomycosis in patients attending a dermatology clinic in northeastern Ohio for other conditions [J].
Elewski, BE ;
Charif, MA .
ARCHIVES OF DERMATOLOGY, 1997, 133 (09) :1172-1173
[6]   A large-scale North American study of fungal isolates from nails: The frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns [J].
Ghannoum, MA ;
Hajjeh, RA ;
Scher, R ;
Konnikov, N ;
Gupta, AK ;
Summerbell, R ;
Sullivan, S ;
Daniel, R ;
Krusinski, P ;
Fleckman, P ;
Rich, P ;
Odom, R ;
Aly, R ;
Pariser, D ;
Zaiac, M ;
Rebell, G ;
Lesher, J ;
Gerlach, B ;
Ponce-de-Leon, GF ;
Ghannoum, A ;
Warner, J ;
Isham, N ;
Elewski, B .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2000, 43 (04) :641-648
[7]   Therapies for onychomycosis: A review [J].
Gupta, Aditya K. ;
Tu, Linh Q. .
DERMATOLOGIC CLINICS, 2006, 24 (03) :375-+
[8]  
HAO J, 2008, J PHARM SCI, V97, P1
[9]   Chemical method to enhance transungual transport and iontophoresis efficiency [J].
Hao, Jinsong ;
Smith, Kelly A. ;
Li, S. Kevin .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 357 (1-2) :61-69
[10]   Transungual iontophoretic transport of polar neutral and positively charged model permeants: Effects of electrophoresis and electroosmosis [J].
Hao, Jinsong ;
Li, S. Kevin .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 97 (02) :893-905